🔎 Trials Near Me

홈 › 삼중음성 유방암 › 텍사스 › Houston

TX Houston의 삼중음성 유방암 임상 시험

삼중음성 유방암 관련 연구 42개가 Houston 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.

공식 연구 텍스트(영어)

연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

피험자 모집 중1상
  • University of Texas MD Anderson Cancer Center, Houston
  • NEXT Houston, Houston
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06270706

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

피험자 모집 중1상
  • University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06465069

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

피험자 모집 중1/2상
  • The University of Texas MD Anderson Cancer Center, Houston
12세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT04585750

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

피험자 모집 중1/2상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT07189871

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

피험자 모집 중1/2상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT06799065

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

피험자 모집 중
  • M D Anderson Cancer Center, Houston
30세 이상 · 여성 · 2026. 9. 25. 업데이트됨 · NCT02945579

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

피험자 모집 중3상
  • Kelsey-Seybold Clinic - North Houston Campus ( Site 0096), Houston
  • Kelsey-Seybold Clinic ( Site 0040), Houston
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06841354

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

피험자 모집 중3상
  • Oncology Consultants P.A. ( Site 0107), Houston
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06393374

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

피험자 모집 중3상
  • Kelsey-Seybold Clinic ( Site 0042), Houston
  • Kelsey-Seybold Clinic ( Site 0088), Houston
  • Oncology Consultants P.A. ( Site 0073), Houston
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06966700

Intratumoral N17350 in Advanced Solid Tumors

피험자 모집 중1/2상
  • The University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07339176

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

피험자 모집 중1상
  • Oncology Consultants, P.A., Houston
  • University of Texas M.D. Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT05983432

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

피험자 모집 중1상
  • The University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT07705334

Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies

피험자 모집 중2상
  • Baylor College of Medicine, Houston
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT07340541

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

피험자 모집 중1상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07020117

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

피험자 모집 중3상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT05633654

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

피험자 모집 중1상
  • The University of Texas - MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT06400472

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

피험자 모집 중관찰 연구
  • UT Health Houston, Houston
18세 ~ 99세 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT07211178

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

피험자 모집 중1상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT07029399

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

피험자 모집 중1/2상
  • Research Site, Houston
18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT07115043

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

피험자 모집 중1상
  • Normunity Investigational Site, Houston
18세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT07182149

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

피험자 모집 중1/2상
  • Houston Methodist Hospital, Houston
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT04895709

SMP-3124LP in Adults With Advanced Solid Tumors

피험자 모집 중1/2상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 8. 12. 업데이트됨 · NCT06526819

Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer

피험자 모집 중1상
  • UT MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 8. 10. 업데이트됨 · NCT05111561

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

피험자 모집 중2/3상
  • (USOR) Texas Oncology, Houston
18세 이상 · 모든 성별 · 2026. 8. 10. 업데이트됨 · NCT06926868

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

피험자 모집 중1상
  • Uni Of TX MD Anderson Cancer Cntr, Houston
18세 ~ 100세 · 모든 성별 · 2026. 7. 29. 업데이트됨 · NCT06562192

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

피험자 모집 중1상
  • The University of Texas MD Anderson Cancer Center Investigational Pharmacy Services, Houston
  • The University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 7. 22. 업데이트됨 · NCT05208762

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

피험자 모집 중1상
  • The University of Texas - M.D. Anderson Cancer Center, Houston
  • The University of Texas, MD Anderson Cancer Center - West Houston, Houston
18세 이상 · 모든 성별 · 2026. 7. 22. 업데이트됨 · NCT07318805

Study of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC)

피험자 모집 중1/2상
  • The University of Texas M. D. Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 7. 7. 업데이트됨 · NCT07011654

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

피험자 모집 중1/2상
  • MD Anderson, Houston
18세 이상 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT05377996

A Study of LY4175408 in Participants With Advanced Cancer

피험자 모집 중1상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 6. 23. 업데이트됨 · NCT07046923

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

피험자 모집 중1상
  • The University of Texas MD Anderson Cancer Center /ID# 270059, Houston
18세 이상 · 모든 성별 · 2026. 6. 23. 업데이트됨 · NCT05005403

Study of XB010 in Subjects With Solid Tumors

피험자 모집 중1상
  • University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 6. 22. 업데이트됨 · NCT06545331

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

피험자 모집 중1상
  • MD Anderson, Houston
  • NEXT Texas LLC - Houston, Houston
18세 이상 · 모든 성별 · 2026. 6. 18. 업데이트됨 · NCT07503808

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

피험자 모집 중1상
  • The University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 6. 15. 업데이트됨 · NCT05768932

Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)

피험자 모집 중2상
  • Houston Methodist Neal Cancer Center, Houston
  • The University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 6. 4. 업데이트됨 · NCT05660083

Open-label, Single Center, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab in Combination With Carboplatin and Paclitaxel in Patients With Stage 1 cT1b-T1cN0M0 Triple Negative Breast Cancer

피험자 모집 중2상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 3. 4. 업데이트됨 · NCT06318897

PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer

피험자 모집 중1상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 2. 23. 업데이트됨 · NCT07190469

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

피험자 모집 중1/2상
  • M.D. Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2025. 11. 4. 업데이트됨 · NCT05902988

Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

피험자 모집 중1/2상
  • The University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2025. 10. 29. 업데이트됨 · NCT06249048

A Study of NX-1607 in Adults With Advanced Malignancies

피험자 모집 중1상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2025. 9. 9. 업데이트됨 · NCT05107674

Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer

피험자 모집 중2상
  • Harris Health System - Smith Clinic, Houston
  • O'Quinn Medical Tower - McNair Campus - Dan L Duncan Comprehensive Cancer Center, Houston
18세 이상 · 모든 성별 · 2025. 2. 27. 업데이트됨 · NCT05020860

CtDNA Based MRD Testing for NAC Monitoring in TNBC

피험자 모집 중관찰 연구
  • The University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 여성 · 2025. 1. 7. 업데이트됨 · NCT06230185

다른 도시의 삼중음성 유방암 시험

Houston의 다른 연구

ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.